Aglaia closes $65M for Oncology Fund II

Dutch VC firm Aglaia BioMedical Ventures B.V. launched its Oncology Fund II with a $65 million close. The VC is aiming to raise $80-$100 million to invest in 10-15 cancer-focused biotech start-ups. Investors include European Investment Fund (EIF) and unnamed institutional investors. ...